Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults-Reference-Cited by-同舟云学术

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

Published:2010-08 Issue:38 Volume:28 Page:6367-6373
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Frey Sharon E.,Houghton Michael,Coates Stephen,Abrignani Sergio,Chien David,Rosa Domenico,Pileri Piero,Ray Ranjit,Di Bisceglie Adrian M.,Rinella Paola,Hill Heather,Wolff Mark C.,Schultze Viola,Han Jang H.,Scharschmidt Bruce,Belshe Robert B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. Long-term mortality after transfusion-associated non-A, non-B hepatitis;Seeff;N Engl J Med,1992

2. The natural history of community-acquired hepatitis C in the United States;Alter;N Engl J Med,1992

3. Clinical outcomes after transfusion-associated hepatitis C;Tong;N Engl J Med,1995

4. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients;Fattovich;Gastroenterology,1997

5. Hepatitis C, after orthotopic liver transplantation;Araya;Gastroenterology,1997

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches;Journal of Medical Virology;2024-09

2. Update on Hepatitis C Vaccine: Results and Challenges;Viruses;2024-08-21

3. Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance;Immunity;2024-04

4. Hepatitis C virus modified sE2 _F442NYT as an antigen in candidate vaccine facilitates human immune cell activation;Journal of Virology;2024-01-23

5. Prospects for developing an Hepatitis C virus E1E2‐based nanoparticle vaccine;Reviews in Medical Virology;2023-08-11